Projects Funded by the NATIONAL SCIENCE CENTRE

• “Alicyclic amine derivatives as a potential therapeutic option for infections caused by multidrug-resistant Enterococcus spp. strains.”
  Project No. DEC-2023/07/X/NZ6/01095 – Project Leader: Dr. Karolina Klesiewicz

• “Antimicrobial and antibiofilm properties of new arylsulfonamide derivatives against multidrug-resistant Staphylococcus epidermidis biofilm-producing strains.”
  Project No. DEC-2018/31/N/NZ6/03339, PRELUDIUM 16 – Project Leader: MSc. Iwona Skiba-Kurek, Scientific Supervisor: Dr. habil. Elżbieta Karczewska, Prof. UJ (2019-2022)

Projects Funded by the Statutory Funds for Maintaining and Developing the Research Potential of Jagiellonian University Medical College

• “In vitro activity of cefiderocol against multidrug-resistant Acinetobacter baumannii clinical isolates.”
  Project No. N42/DBS/000397 (2024-2025) – Project Leader: Dr. Iwona Skiba-Kurek

• “Investigation of the adjuvant activity of new arylideneimidazolone derivatives for beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus strains.”
  Project No. N42/DBS/000398 (2024-2025) – Project Leader: Dr. Karolina Witek

• “Assessment of the activity of newly synthesized compounds from the arylalkylamine group and derivatives of azaheterocyclic systems against multidrug-resistant bacteria classified as priority pathogens.”
  Project No. N42/DBS/000346 (2023-2024) – Project Leader: Dr. Karolina Klesiewicz

• “Investigation of the presence and expression of genetic determinants responsible for biofilm formation in clinical Staphylococcus epidermidis strains – Real-Time PCR analysis using TaqMan probes. Biofilm imaging.”
  Project No. N42/DBS/000295 (2022-2023) – Project Leader: MSc. Iwona Skiba-Kurek

• “Investigation of the ability of hydantoin derivatives to inhibit bacterial resistance mechanisms against antibacterial drugs.”
  Project No. N42/DBS/000296 (2022-2023) – Project Leader: Dr. Karolina Witek